Hybrid Conferencee

International Congress on Immunology and Clinical Applications (ICI-CA - 26)

3rd - 4th September 2026 | Nairobi, Kenya

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Nairobi. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Nairobi event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Nairobi conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Nairobi, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Nairobi."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Immunotherapy

This track will explore the latest breakthroughs in immunotherapy for various diseases, focusing on novel therapeutic strategies and their clinical applications. Participants will discuss the mechanisms of action and efficacy of emerging immunotherapeutic agents.

Track 02

Autoimmune Diseases: Mechanisms and Management

This session will delve into the pathophysiology of autoimmune diseases and the latest approaches to their management. Emphasis will be placed on innovative therapies and personalized medicine strategies.

Track 03

Infectious Diseases and Immune Response

This track will examine the immune response to infectious diseases, highlighting the role of immune modulation in treatment and prevention. Discussions will include vaccine development and the challenges posed by emerging pathogens.

Track 04

Vaccine Development and Immunization Strategies

This session will focus on the latest advancements in vaccine development, including novel platforms and adjuvants. Participants will discuss strategies for enhancing vaccine efficacy and addressing public health challenges.

Track 05

Immune Biomarkers in Clinical Practice

This track will explore the role of immune biomarkers in diagnosing and monitoring diseases, as well as their potential in predicting treatment responses. Emphasis will be placed on the integration of biomarker discovery into clinical practice.

Track 06

Regulation of Immune Responses

This session will investigate the mechanisms underlying immune regulation and tolerance, with a focus on their implications for therapy. Discussions will include the role of regulatory T cells and cytokines in maintaining immune homeostasis.

Track 07

Immunodeficiency Disorders: Diagnosis and Therapy

This track will address the challenges in diagnosing and managing immunodeficiency disorders. Participants will discuss recent advancements in genetic therapies and immunomodulatory treatments.

Track 08

Cancer Immunotherapy: Current Trends and Future Directions

This session will highlight the current landscape of cancer immunotherapy, including checkpoint inhibitors and CAR T-cell therapy. Discussions will focus on overcoming resistance and improving patient outcomes.

Track 09

Cytokine Therapy: Mechanisms and Applications

This track will explore the therapeutic potential of cytokine therapy in various diseases, including cancer and autoimmune disorders. Participants will discuss the mechanisms of action and clinical outcomes associated with cytokine-based treatments.

Track 10

Cellular and Humoral Immunity in Health and Disease

This session will examine the roles of cellular and humoral immunity in maintaining health and combating diseases. Emphasis will be placed on the interplay between different immune components and their therapeutic implications.

Track 11

Clinical Trials in Immunology: Design and Challenges

This track will focus on the design and execution of clinical trials in the field of immunology, addressing regulatory, ethical, and logistical challenges. Participants will share insights on optimizing trial outcomes and patient recruitment.